To examine factors determining the haemodynamic and metabolic responses to treatment of diabetic ketoacidosis with alkali, groups of anaesthetised and ventilated rats with either diabetic ketoacidosis (mean arterial pH 6.86-6.96, mean arterial blood pressure 63-67 mmHg) or hypovolaemic shock due to blood withdrawal (mean pH a 7.25-7.27, mean arterial blood pressure 36-41mmHg) were treated with sodium chloride ('saline'), sodium bicarbonate or 'Carbicarb' (equimolar bicarbonate plus carbonate). In the diabetic ketoacidosis series, treatment with either alkali resulted in deterioration of mean arterial blood pressure and substantial elevation of blood lactate, despite a significant rise in myocardial intracellular pH determined by 31p-magnetic resonance spectroscopy. These effects were accompanied by falling trends in the ratios of myocardial phosphocreatine and ATP to inorganic phosphate. Erythrocyte 2,3-bisphosphoglycerate was virtually absent in animals with diabetic ketoacidosis of this severity and duration. In contrast, in shock due to blood withdrawal, infusion of saline or either alkali was accompanied by a transient elevation of mean arterial blood pressure and no significant change in the already elevated blood lactate; erythrocyte 2,3-bisphosphoglycerate was normal in these animals. The effect of alkalinization in rats with severe diabetic ketoacidosis was consistent with myocardial hypoxia, due to the combination of very low initial erythrocyte 2,3-bisphosphoglycerate, alkali-exacerbated left shift of the haemoglobin-oxygen dissociation curve and artificial ventilation. No evidence was found for any beneficial effect of 'Carbicarb' in either series of animals; 'Carbicarb' and sodium bicarbonate could be deleterious in metabolic acidosis of more than short duration. [Diabetologia (1995) 38: 889-898] 
PaCO2, arterial PCO2; Pi, inorganic phosphate; PCr, phosphocreatine; MRS, magnetic resonance spectroscopy; MABR mean arterial blood pressure.
Arieff et al. [3, 4] have cast doubt on the value of sodium bicarbonate in the treatment of metabolic acidosis [5] . In both experimental phenformin-induced lactic acidosis and in lactic acidosis induced by the breathing of hypoxic gas mixtures, sodium bicarbonate treatment was disadvantageous compared with saline in respect of haemodynamics, blood lactate and hepatic intracellular pH. Because some have argued [6] [7] [8] [9] that the deleterious effect of sodium bicarbonate is due to its immediate effect in elevating arterial PCO2 (PaCO2), with consequent intracellular acidification, therapies which avoid this effect have been developed. Of these, an equimolar mixture of sodium carbonate and sodium bicarbonate, devised by Filley and Kindig [6] and named 'Carbicarb' is the best known. Comparisons of the effects of saline, sodium bicarbonate and 'Carbicarb' have been made in several animal models [10] [11] [12] . However, few of these have attempted to emulate the severe acidosis, circulatory insufficiency and duration of acidosis which are common features of clinical DKA, in which decisions on alkalinizing therapy have currently to be made on an empirical basis. The purpose of the present studies was to identify some of the factors which could determine the response to sodium bicarbonate and to 'Carbicarb' in such circumstances.
There is evidence that the deleterious effects of acidosis on haemodynamics and aspects of metabolism are related to falls in intracellular pH (pHi) in critical organs. Specifically, this appears to be the case for the negative inotropic effect of systemic acidosis [13, 14] and for the inhibition of hepatic gluconeogenesis from lactate [15, 16] . It is therefore a testable hypothesis that therapies which correct intracellular acidosis are advantageous in haemodynamic and metabolic terms. It should be noted that, apparently uniquely in DKA, hepatic pH i does not fall appreciably, despite severe systemic acidosis [17] ; there is no reason, however, to suppose that this protection extends to myocardial pH i .
For this reason, in the present study we measured myocardial pH i and indices of energy metabolism, together with blood pressure and blood lactate before and after therapy in rats with severe diabetic ketoacidosis induced over 48 h. For comparison with a much more acute acidosis, we also report observations using the same treatment regimens in rats with lactic acidosis due to hypovolaemia induced by withdrawal of blood.
Materials and methods
Diabetic ketoacidosis model Male Wistar rats (weight approximately 400 g) were rendered diabetic by a single intravenous injection of streptozotocin (100 mg/kg) and were then starved for 48 h, by which time severe diabetic ketoacidosis (DKA) had developed. The rats were then anaesthetised with pentobarbitone (60 mg/kg) and a jugular vein and carotid artery cannulated, before preparation for magnetic resonance observations of cardiac intracellular pH (pHi) and high energy phosphates. An arterial blood sample was then obtained and arterial blood pH (pHa) and PaCO2 determined. A tracheostomy was performed and artificial ventilation established, using a ventilation frequency of 58/min and a variable stroke volume. Through a mid-line sternotomy an 8-mm diameter surface coil was placed over and in contact with the left ventricle and the edges of the wound held slightly apart with a brass self-retaining retractor. Neuromuscular blockade was induced with pancuronium (4 mg/kg). The stroke volume of the ventilator was then adjusted to give the same P~CO2 as had been observed before surgery. Three samples of arterial blood were taken over the next 15 min for measurement of pHa, PaCO2, bicarbonate ([HCO3-]a), glucose, lactate and 3-hydroxybutyrate. Mean arterial blood pressure was recorded via the carotid cannula us-J. S. Beech et al.: Alkali treatment in diabetic ketoacidosis ing a Statham strain gauge. The animal was then positioned in a supine position in the bore of the magnetic resonance spectrometer (see below), and a baseline measurement of myocardial pH i was obtained as described below.
The animals were then assigned to one of three treatment groups. Group i received an intravenous infusion (3-6 mmol/ kg) of 1 mol/1 sodium chloride ('saline') over 3 min. Group 2 received sodium bicarbonate, 1 mol/1, and Group 3 'Carbicarb' (solution containing 0.33 tool/1 sodium bicarbonate and 0.33 mol/1 sodium carbonate -i. e. equivalent in base per litre to i mol/1 sodium bicarbonate) in volumes over 3 min calculated to correct the plasma bicarbonate to 25 mmol/1, using the following formula:
Typically, the amount of alkali infused was 3-6 mmol/kg.
A further measurement of myocardial pH i was made over the 18 min following the infusion.
31P-magnetic resonance spectrometry (MRS) studies.
These were performed at 81 MHz in a 4.7 T 30-cm diameter horizontal bore superconducting magnet controlled by a SISCO 200 imaging spectrometer. The rat was positioned in the probe on a warm pad and the heart monitored by ECG throughout. Myocardial pHi was measured by determination of the pH-dependent chemical shift of the phosphorus resonance of inorganic phosphate (Pi) with respect to phosphocreatine. We used the technique described by Zahler et al. [18, 19] to abstract the signal due to myocardial Pi from the combined signal due to blood Pi and 2,3-bisphosphoglycerate and myocardial Pi. The principle is to apply a long selective radiofrequency pulse which saturates the signals from these three resonances of comparable chemical shift, If a delay of sufficient length is then incorporated before inserting another (non-selective) radiofrequency read-out pulse, the blood containing the previously saturated Pi and 2,3-bisphosphoglycerate (2,3-BPG) phosporus nuclei will have moved on from the region of interest; fresh blood entering the heart will be unsaturated and will therefore result in an observable resonance, whereas the Pi within the myocardium remains saturated, thus yielding a negligible signal contribution. If the frequency of the saturating pulse is then moved to a point in the spectrum remote from Pi and 2,3-bisphosphoglycerate (in practice to the position of the /3-ATP signal, 22 ppm upfield from Pi and 2,3-bisphosphoglycerate), and the protocol repeated, the spectrum recorded will contain the combined signal described above. Subtraction of the first spectrum from the second yields the myocardial Pi peak, from which the pH i can be obtained. The technique assumes that the signal contributed by Pi in the myocardial interstitial space and capillaries is small compared with that from within cardiac myocytes. In practice, the position of the saturating pulse was alternated every four scans. Since the heart rate is slowed in severely acidotic rats (mean 271 beats per rain in three rats with arterial pH 6.69-6.88, compared with 360 beats per min in normal animals), the length of the delay after the saturation pulse required consideration. Measurement of left ventricular dimensions in diastole and systole in a cine-magnetic resonance image sequence of normal rat heart indicated an ejection fraction between 70 and 60 % (Beech, unpublished observations). After two beats, therefore, residual saturation was well below 10 %. Together with the observation that the mean Pi signal from ventricular blood is relatively small compared with the total Pi signal (median 6 %, range < 4-34 % pre-infusion, median 24.5 %, range < 4-49 % post-infusion; n = 16), this data suggested that a delay of 450 ms, as employed by Zahler et al. [18] was adequate, and this would still be the case if the ejection fraction was as low as 40 % in acidotic rats. A delay of 450 ms was therefore used in all the cardiac MRS studies. A pulse repetition time of 1.96 s was employed and an 18-min total acquisition time was needed to obtain adequate signal/noise ratio (256 repetitions). The duration of the non-selective pulse was 17 ~ts. Since the post-infusion period does not represent a steady state, the pH i measurement has to be regarded as a time average over that period, pH i was determined by a computer programme which automatically detects the peak value of the Pi resonance and compares the chemical shift with the computer-held titration curve of Pi.
Estimates of myocardial phosphocreatine (PCr), ATP and Pi were made by measurement of peak areas in the spectra obtained before and after infusion. In the case of Pi, the subtraction spectrum was used. For PCr and ATP the spectrum obtained when the saturation pulse was in the Pi/2,3-bisphosphoglycerate position was employed. For technical reasons it is not possible to use the the subtraction spectrum for ATR so the assumption was made, as did Zahler et al. [19] when interpreting the effects of treatment on myocardial ATR that erythrocyte ATP changes are not different between the groups and are in any case small. The results are expressed as PCr/ATP, PCr/Pi and ATP/Pi for this method.
At the end of the post-infusion period the animal was removed from the spectrometer and a further 1 ml of arterial blood was obtained for repeat measurement of acid base variables, lactate and 3-hydroxybutyrate, and mean arterial blood pressure.
Since it was not practicable to make frequent observations whilst the animal was in the spectrometer, a further series of experiments was performed in which the procedures were identical in all respects, including the sternotomy and artificial ventilation, except for the taking of serial blood samples (200 ~1, replaced by saline) and the animal not being placed in the spectrometer. These studies are referred to as 'bench' experiments.
Hypovolaemic shock model. Rats were anaesthetized, sternotomy performed and artificial ventilation instituted as for the DKA model. They were then rendered hypovolaemic by successive withdrawal of blood from the jugular vein over about 30 min in a manner previously described [20] , until the mean arterial blood pressure, recorded with a Statham strain gauge reached 40mmHg. A 60-120rain period was allowed to elapse until pH~ was in the range 7.2-7.3. Groups of animals then received the same treatment regimens as for the diabetic ketoacidosis model. It did not prove possible to maintain the majority of these severely hypovolaemic animals in a stable condition in the spectrometer. However, we were able to make observations in 'bench' experiments as for the diabetic animals. The sternotomy and artificial ventilation were employed to permit comparison of the bench experiments in the DKA and hypovolaemic series.
Analytical methods, pHa, PaCO2 and [HCO3-]~ were measured
with an IL 1304 blood gas analyser. Lactate and 3-hydroxybutyrate were measured on perchloric acid extracts of whole blood by standard enzymatic methods [21, 22] . All reagents were of analytical grade. For measurements of erythrocyte 2,3-bisphosphoglycerate (2,3-BPG), approximately 5 ml arterial blood was taken into preweighted tubes containing 10 ml 0.6 mol/1 perchlorie acid, which were then reweighed, and centrifuged. Neutralized perchlorate extract (4 ml) was then placed in a Bruker AM250 high field magnetic resonance spectrometer and 31p spectra accumulated at 100 MHz, using a simple pulse-acquire sequence. Phosphocreatine (5 mmol/1) was 891 used both as an internal standard and a chemical shift reference. Comparison of peak areas of the signals from the 3-phosphate of 2,3-BPG and phosphocreatine was used to estimate 2,3-BPG concentration. Haemoglobin and packed cell volume were measured using a Coulter counter and 2,3-BPG expressed as mmol/1 blood or mol/mol haemoglobin.
Statistical analysis
For comparing means within the same treatment group in the MRS studies before and after infusion, two-tailed paired ttest were used. Comparison of post-treatment means between groups was performed using analysis of covariance, adjusting for differences in pre-treatment values. Analysis of variance was used to compare treatment effects between treatment groups. For comparing the effects of different treatments in the bench experiments, the method of summary statistics with analysis of covariance was used [23, 24] . The summary statistic employed was the mean of all the data for a given variable from 2 to 20 min. The baseline value of the variable was used as a covariate.
Results
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MRS observations. Figure i shows the spectra obtained with and without suppression of the myocardial inorganic phosphate (Pi) signal, and the difference spectrum from which myocardial pH i was derived. Table i shows PaCO2, myocardial pH i and arterial lactate and 3-hydroxybutyrate concentrations before and after treatment. The severity of the ketoacidosis is demonstrated by the pre-infusion arterial pH (pHa) and 3-hydroxybutyrate values which are similar for all groups. Arterial blood glucose was in the range of 15-22 mmol/1. The baseline levels of PaCO2 were low in all groups, indicating that the artificial ventilation maintained a degree of respiratory compensation. Though no significant difference at baseline was seen between the groups in myocardial pHi; there was a tendency for a lower mean value in the group that subsequently received saline.
The effect of treatment is also shown in Table 1 . Marked and similar elevations of pH a were produced in the groups treated with sodium bicarbonate and 'Carbicarb', but there was no significant change in the saline group. In the sodium bicarbonate and 'Carbicarb' groups there were highly significant elevations in myocardial pH i (means 0.16 and 0.22 pH units, respectively), and a slight but significant fall in the saline group. At the end of the infusion there was a significant elevation of PaCO2 from baseline in the sodium bicarbonate and 'Carbicarb' groups, but not in the saline group. There were highly significant elevations of blood lactate in the alkali-treated groups, but that in the saline group was not significant. There was also significant elevation of blood 3-
Fig. 1. 31P-MRS spectra of heart in vivo in animals with diabetic ketoacidosis. In the lowest spectrum the saturation pulse is at the position of the Pi/2,3-BPG signal; only myocardial Pi is saturated so the spectrum reflects that of the moving blood in the cardiac chambers. In the middle spectrum the frequency of the saturation pulse is at approximately the position of the/3-ATP signal, which is partially suppressed, due to saturation of the myocardial component. The top spectrum is derived by subtraction of the lower from the middle spectrum, and shows the myocardial Pi peak. from the chemical shift of which pH i is derived. Because of the depletion of 2,3-BPG in the DKA animals, its resonance is virtually absent in these spectra hydroxybutyrate in the sodium bicarbonate group. When treatment effects were compared between groups by analysis of variance, significances (Table 1) which were broadly similar to those found for comparisons of base-line adjusted post-treatment values were demonstrated for the different variables; however, elevation of lactate in the bicarbonate group compared with that in the saline group was of borderline significance (p = 0.038), and was highly significant for 'Carbicarb' (p -0.008). Table 2 provides data on several indices of myocardial energy status before and after saline or alkali therapy in the three groups. These data were obtained from the same experiments as in Table 1 , but for each group the number of studies analysed was reduced by one because of unsatisfactory signal/noise ratio in the excluded studies. There was clearly no effect of saline on PCr/ATR PCr/Pi and ATP/Pi. In the alkali-treated groups there was a trend to decreased PCr/Pi and ATP/Pi post-treatment, which almost reached conventional significance in the 'Carbicarb' group; if the data from both alkali-treated groups were pooled, the fall in both PCr/Pi and ATP/Pi were significant at p < 0.05; these statistics should, Data are means + SEM. The significance of differences posttreatment from mean values in the saline group (having adjusted for baseline differences -see Methods) is given by: ap < 0.05; Up < 0.01; Cp < 0.001. The significance of the mean difference within the same treatment group pre-and post-treatment is shown by: ap < 0.05; ep < 0;01 however, be treated with caution, since when the changes in these variables in the alkali-treated groups were compared with those in the saline group, they were not significantly different (p = 0.18 and p = 0.19, respectively).
Bench experiments. Table 3 shows the baseline values of pHa, PaCO2, [HCO3-]a , blood lactate and 3-hydroxybutyrate. These were similar to those in the MRS studies (Table 1 ). The baseline mean arterial blood pressure (MABP) did not differ between the groups and the mean for each group was in the range 62-67 mmHg. Comparison with our previous data and those of Zahler et al, [19] indicate that the present study animals were substantially hypotensive. Figure 2 shows the detailed time course of the changes in pHa, PaCO2, blood lactate and MABP from the start of the 3-min infusion period until 20 rain later. When all three treatment groups were compared in a single analysis of covariance, the means over time after commencement of treatment for arterial blood pH, [HCO3-] and [lactate] were highly significantly different between the bicarbonate and saline groups and between the 'Carbicarb' and saline groups (p = 0.001). For PaCO2, using analysis of covariance, the mean over time in the bicarbonate group was significantly greater than that in the saline group (p = 0.02); in contrast, the mean over time in the 'Carbicarb' group was not significantly different or 'Carbicarb' ( 9 as described in 'Methods'. The baseline data from these studies is given in Table 3 . The error bars represent SEM; statistical analysis is given in the text Table 2 . Myocardial PCr/ATR PCr/P i and ATP/P i before and after infusion into diabetic ketoacidotic rats of saline (n = 4), sodium bicarbonate (n = 4) or 'Carbicarb' (n = 5) in the 31p~ magnetic resonance experiments Group PCr/ATP PCr/P i ATP/P i from that in the saline group (p = 0.09). The baseline value of PaCO2 was not significantly associated with the post-treatment mean, so that analysis of variance gave p = 0.02 and p = 0.03 for the changes in the bicarbonate and 'Carbicarb' treated groups, respectively, compared with those in the saline group. For MABP (Fig. 2) , the mean over time post-treatment was very significantly lower in the 'Carbicarb' group 
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than in the saline group (p = 0.01); there was a similar trend in the comparison between the bicarbonate group and the saline group, but this difference just failed to reach conventional significance (p = 0.056).
Comparing the bicarbonate and 'Carbicarb' groups alone, there were no significant differences over time for [HCO3-], [lactate], PaCO2, pHa or MABR However, with the numbers of animals used in each group in the present studies, only a difference as large as 12 mmHg in MABP could have been detected with 80 % power (at p = 0.05). Erythrocyte 2,3-BPG was measured in arterial blood in a separate group of six control rats and six animals with DKA, at 48 h after injection of streptozotocin, i.e. at the point in the development of the condition when treatment was instituted in the MRS and bench studies. Figure 3 shows typical spectra in the Pi/2,3-BPG region. It is clear that 2,3-BPG is below the minimum detectable concentration (0.3 mmol/1 blood) in blood from this DKA animal and this was also the case in the five other rats with DKA. In blood from normal rats the mean concentration of 2,3-BPG was 3.32 + 0.20 mmol/1 blood, equivalent to 1.65 tool per mol haemoglobin. Table 4 shows baseline mean values of pHa, PaCO2 arterial blood [lactate] and MABP in the bench studies in the three treatments groups; these were similar, though small differences (p < 0.05) were seen in arterial lactate and MABR It may be noted that the ani- Hg.3, 31p-MRS spectra of perchloric acid extracts of blood from normal (left), DKA (middle) and hypovolaemic shock (HVS) (right) rats. The largest resonance is that of phosphocreatine, added as a reference and quantification standard. Note the virtual absence of the 2,3-BPG signal in the extract from the DKA rat. The greater separation between the Pi and 2-P of DPG seen in the spectrum in the extract from the shocked animal compared with that from the normal animal is purely technical and is due to a minor difference in the neutralization of the perchloric extract Data are means + SEM. There were no statistically significant differences between the variables in any of the groups mals were less acidotic, more hypotensive and had much higher blood lactate than in the DKA series. The time course of the changes in these variables on treatment is shown in Figure 4 . There were, as expected, highly significant differences in the summary statistics analysis considering the three treatment groups together between the saline group on the one hand and the bicarbonate and 'Carbicarb' groups on the other for pH a (p < 0.001); however, there were no significant differences in the mean post-treatment PaCO2 . For blood lactate, there was a trend towards a higher mean value in the 'Carbicarb' than in the saline group but this did not quite reach significance (p = 0.07). Though Figure 4 suggests that the mean post-treatment MABP was (in contrast to the findings in the DKA series) more favourable in the alkali-treated groups, neither in the bicarbonate group (p = 0.21) or in the 'Carbicarb' group (p = 0.84) was this significant. Comparing the two alkali groups alone, there were no significant differences in the summary statistics analysis for any variable. Erythrocyte 2,3-BPG was measured (Fig. 3) in a separate series of five animals subjected to an identical protocol of blood withdrawal to induce hypovolaemic shock. Mean 2,3-BPG was 2.19 + 0.1 mmol/ 1 blood, which taking into account the haemodilution to a mean of 9.6 + 0.16 g/dl seen in the hypovolaemic animals from the normal value of 13.1 + 0.47 g/dl is equivalent to 1.46 mol per mol haemoglobin, similar to the value obtained in normal animals.
Hypovolaemic shock
Per
Discussion
These studies were designed to test the effects of different types of alkalinization on myocardial pHi, MABP and blood lactate in an animal model of diabetic ketoacidosis, using acute hypovolaemia due to blood withdrawal as a model of a more acute metabolic acidosis for comparison. The studies were not intended to emulate therapeutic protocols for clinical diabetic ketoacidosis and hypovolaemic shock, but to examine some of the factors which determine the haemodynamic and metabolic response to bicarbonate and 'Carbicarb'. The results from the present studies cannot necessarily be extrapolated to other models differing in their pathophysiological status.
Because of the severity factor we found it more practical to perform a parallel series of bench experiments rather than sample from animals whilst in the The baseline data in the bench studies in DKA animals closely resemble those in the MRS studies. We therefore assume that the detailed subsequent time courses of the variables studied were similar in the MRS and bench studies. It should be noted that because of the decrease of erythrocyte 2,3-BPG to unrecordable levels in the animals with DKA, the MRS subtraction technique was only concerned with removal of the error from blood Pi in the ventricular cavity.
The most striking findings in the DKA model are the substantial rise in myocardial pH i that occurred on infusion of sodium bicarbonate or 'Carbicarb', the deleterious effects on MABP and the marked rise in blood lactate that were seen in the alkali-treated groups but not in the saline group. The rise in myocardial pH i during bicarbonate infusion contrasts with the findings of Zahler et al. [19] in rats receiving acute lactic acid infusions; they observed no significant change in either myocardial pH i or systolic blood pressure. In the study of Rhee et al. [25] in dogs with acute hypoxic lactic acidosis, myocardial pH i was stated to have improved more with 'Carbicarb' than with sodium bicarbonate or chloride. There was a positive relationship between pH a and pH i which was similar in all treatment groups in that study, but subtraction techniques were not used to eliminate contributions to the signals from intracavitary Pi and 2,3-BPG; cardiac index was more favourably affected with 'Carbicarb' than with saline, and MABP was better sustained in both alkali-treated groups than with saline. In a similar study in acute hypoxic lactic acidosis in rats, Sun et al. [26] found that 'Carbicarb' had advantages over bicarbonate in respect of pHa, MABP and blood lactate, but did not measure myocardial pH i.
Since myocardial pH i rose in the alkali-treated rats with DKA, the relative post-treatment hypotension in those groups cannot be attributed to the negative inotropic effect of myocardial acidification, which has been proposed as a reason for the adverse haemodynamic effect of sodium bicarbonate in metabolic acidosis due to ventilation with hypoxic gas mixtures [9] . Indeed, the data of Steenbergen et al. [13] suggests that the rise in phi seen in the present studies would, if taking place in the absence of other factors, have produced a significant positive inotropic effect. The cause of the relative hypotension in the alkalitreated groups remains to be conclusively demonstrated. However, the present observations are consistent with the suggestion that it was due to the effect on cardiac function of alkali-induced acute left shift of the haemoglobin-oxygen dissociation curve on a background of the marked depletion observed of erythrocyte 2,3-BPG. Data in human erythrocytes [27] suggest a decrease in Ps0 (PO2 at half saturation of haemoglobin) of approximately 0.13 kPa (1 mmHg) for each decrement of 0.1 mol 2,3-BPG/ mol haemoglobin. The tendency to lowering of myocardial energy status (PCr/Pi and ATP/Pi) and the substantial elevation of blood lactate in both alkalitreated groups are consistent with induced myocardial and general tissue hypoxia. Other explanations for the hypotension in the alkali-treated groups are possible; for example, if the infusion of alkali produced peripheral vasodilatation, but that of saline did not. We believe this to be less likely, since no such differential effect of alkalinization occurred in the animals with hypotension due to blood withdrawal.
The time course of PaCO2 was significantly elevated in the bicarbonate group over that in the saline group. Yet, in both alkali-treated groups there was an elevation of the time-averaged myocardial pH i . However, in our studies [20] of skeletal muscle pHi response to sodium bicarbonate and 'Carbicarb' in haemorrhagic shock, a similar differential in the course of PaCO2 was also not reflected in pHi, which in that study could be measured at 60-s intervals, because of the availability of the carbon-2 proton resonance of anserine for pHi determination by the more sensitive proton MRS. Furthermore, in the isolated rat liver perfused at acidotic pH, hepatic pH i rises on infusion of bicarbonate, despite a substantial elevation of portal vein PCO 2 [28] . There are clearly determinants of pH i other than PaCO2 [20] and we regard the argument concerning paradoxical intracellular acidification during bicarbonate therapy as of doubtful importance [29] . The risk of such acidification could in any case be eliminated in most clinical situations by slower infusion of bicarbonate than is often customary, thereby allowing respiratory elimination of CO 2 released by titration of bicarbonate [30] .
There was a marked effect of both alkalinizing agents in elevating blood lactate in rats with DKA. However, in a model of severe diabetic ketoacidosis identical to the present one except that it was not necessary to use artificial ventilation, we found no rise in lactate on bicarbonate infusion [28] . Nor in the study of skeletal muscle pH i in hypovolaemic shock referred to above [20] , in which the protocol was similar to that in the present studies, except that thoracotomy and artificial ventilation were not employed, was any elevation of blood lactate observed on infusion of either bicarbonate or 'Carbicarb'. It therefore appears likely that the effect on blood lactate in the present study requires a background of artificial ventilation. Since we have demonstrated that bicarbonate markedly improves disposal of lactate in livers from acidotic and normal rats perfused at pH 6.8, we suggest that in the absence of artificial ventilation increased hepatic uptake of lactate during bicarbonate infusion compensates for increased peripheral production of lactate. However, during positive pressure ventilation the haemodynamic effects of the procedure could decrease hepatic blood flow and thereby impair lactate disposal [31] . Under these circumstances, increased peripheral lactate production would result in hyperlactataemia. Factors leading to elevated lactate production include left shift of the oxygen dissociation curve, the relative hypotension itself and intracellular alkalinization, which counteracts acidotic inhibition of glycolysis at the 6-phosphofructose 1-kinase step [32, 3] . The elevation of blood 3-hydroxybutyrate seen after bicarbonate (Table 1) is presumably due to release of acidotic inhibition of ketogenesis [34] , though the change after 'Carbicarb' is not significant.
The results of alkali treatment in the hypovolaemic shock series differed from those in the DKA animals. Instead of the deterioration in MABP seen in the latter series, there was a transient elevation in all treatment groups, with no significant difference between them. A similar pattern of response was observed in our previous study of skeletal muscle pH i in hypovolaemic shock [20] . Nor was significant elevation of blood lactate observed over the initial high values. Both DKA and hypovolaemic shock animals had been subjected to thoracotomy and similar artificial ventilation, to eliminate these factors as contributing to the different responses to alkali. No-tably, erythrocyte 2,3-BPG was unchanged from normal in the hypovolaemic animals, when expressed in functional terms (tool per mol haemoglobin). We attribute this maintenance of 2,3-BPG to the short duration of the acidosis compared with that in the DKA animals, who had been developing the condition over 48 h. Mild acidosis induced by ingestion of ammonium chloride has been shown over several days to lower 2,3-BPG in man [27] , and there is marked depletion in patients with DKA [35] .
It thus appears likely that both acidosis of many hours duration, leading to 2,3-BPG depletion, and artificial ventilation were required to produce the deleterious response to alkali in the DKA animals. However, it is possible that the lesser degree of acidosis and the more marked hypotension in the hypovolaemic shock series could be additional factors in the differing responses. These studies indicate the substantial range of factors which might determine the response to alkali in clinical metabolic acidosis and suggest that the problem in establishing whether alkali therapy is of clinical benefit [36] may be due to the difficulty in controlling for these factors in the clinical studies that have been attempted. Finally, the results of the present studies give no support to the idea that 'Carbicarb' may be a useful addition to clinical therapeutic options for DKA and hypovolaemic lactic acidosis. No evidence of its haemodynamic or metabolic advantage was seen; particularly in acidoses of substantial duration such as DKA it might be expected to be less satisfactory than bicarbonate, since the effect of the latter in raising PaCO 2 might be expected partially to counter the left shift of the oxygen dissociation curve, an effect which would be absent with 'Carbicarb'.
